HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SCCP Concludes Additional Data Is Needed On Hair Dye, UV Filters

This article was originally published in The Rose Sheet

Executive Summary

An in vitro percutaneous absorption study under oxidative conditions is among the data needed to determine the safety of hair dye ingredient 1-hydroxyethyl-4,5-diamino pyrazole sulfate, the EU's Scientific Committee on Consumer Products concludes in an 1opinion adopted during its June 20 plenary session

You may also be interested in...



CIR Adds To Hair-Care Ingredients On 2015 Priority Review List

CIR adds hair-dye ingredient 1-hydroxyethyl-4,5-diamino pyrazole sulfate and conditioning agent hydrolyzed keratin to its 2015 priority review list, which was approved during the Expert Panel’s June 9-10 meeting in Washington D.C. The panel issued final safety reports for seven ingredients and gave tentative final reports for eight substances.

European Scientific Committee Affirms Safety Of Phthalates At Current Levels

The European Commission's Scientific Committee on Consumer Products maintains that phthalates in cosmetic products at current levels pose no significant risk to consumers

European Scientific Committee Affirms Safety Of Phthalates At Current Levels

The European Commission's Scientific Committee on Consumer Products maintains that phthalates in cosmetic products at current levels pose no significant risk to consumers

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014095

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel